Yüklüyor......
Jumonji domain-containing 6 (JMJD6) identified as a potential therapeutic target in ovarian cancer
Jumonji domain-containing 6 (JMJD6) is a candidate gene associated with tumorigenesis, and JMJD6 overexpression predicts poor differentiation and unfavorable survival in some cancers. However, there are no studies reporting the expression of JMJD6 in ovarian cancer, and no JMJD6 inhibitors have been...
Kaydedildi:
| Yayımlandı: | Signal Transduct Target Ther |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group UK
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6799828/ https://ncbi.nlm.nih.gov/pubmed/31637004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-019-0055-8 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|